Loading chat...

CO SB066

Bill

Status

Introduced

1/28/2026

Primary Sponsor

John Carson

Click for details

Origin

Senate

2026 Regular Session

AI Summary

  • Prohibits sale, transfer, or distribution of compounded weight-loss medications unless bulk drug substances comply with FDA standards, are pharmaceutical-grade, have valid certificates of analysis, and were manufactured at FDA-registered facilities inspected within the previous 2 years

  • Requires labels to list all active and inactive ingredients with quantities and country of origin, plus mandatory warning stating the medication is not FDA-approved, has inadequate evidence of safety or efficacy, and has known and unknown side effects

  • Bans false or misleading advertising claims about compounded weight-loss medications, including failure to disclose potential side effects, contraindications, and the specific pharmacies or outsourcing facilities used

  • Mandates records retention for at least 2 years after medication expiration, with records available to the State Board of Pharmacy within one business day upon request

  • Authorizes fines up to $1,000 per dose for violations, pharmacy or business license revocation, and enforcement by the Attorney General as a deceptive trade practice under the Colorado Consumer Protection Act

Legislative Description

Regulation of Compounded Weight-Loss Medication

Public Health

Last Action

Senate Second Reading Passed with Amendments - Committee, Floor

3/16/2026

Committee Referrals

Committee of the Whole3/5/2026
Health and Human Services1/28/2026

Full Bill Text

No bill text available